Medical Innovation Exchange

Roche, Biogen temper Alzheimer’s expectations in Q2 calls. Will Lilly follow suit in August?

https://www.fiercebiotech.com/biotech/roche-biogen-temper-alzheimers-expectations-q2-calls-will-lilly-follow-suit-august

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!